OMC
OUP Management Company Portfolio holdings
AUM
$44.5M
This Quarter Return
-2.33%
1 Year Return
+54.04%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$44.5M
AUM Growth
+$44.5M
(-24%)
Cap. Flow
-$12.4M
Cap. Flow
% of AUM
-27.78%
Top 10 Holdings %
Top 10 Hldgs %
99.57%
Holding
13
New
1
Increased
–
Reduced
–
Closed
1
Top Buys
| 1 |
IMA
ImageneBio, Inc. Common Stock
IMA
|
$116K |
Top Sells
| 1 |
DICE
DICE Therapeutics, Inc. Common Stock
DICE
|
$12.5M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CNTA
1
Centessa Pharmaceuticals
CNTA
$2.28B
| $19M | 42.74% |
2,937,615
| – | – |
|
|
JBIO
2
Jade Biosciences, Inc. Common Stock
JBIO
$258M
| $8.19M | 18.43% |
603,762
| – | – |
|
|
CYT
3
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
| $6.99M | 15.71% |
2,459,572
| – | – |
|
4
PMV Pharmaceuticals
PMVP
$74.2M
| $6.07M | 13.66% |
989,232
| – | – |
|
|
LENZ
5
LENZ Therapeutics
LENZ
$1.11B
| $1.01M | 2.27% |
406,308
| – | – |
|
6
Cartesian Therapeutics
RNAC
$264M
| $914K | 2.06% |
862,543
| – | – |
|
7
Vor Biopharma
VOR
$258M
| $794K | 1.79% |
374,714
| – | – |
|
|
EFTR
8
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
| $615K | 1.38% |
1,025,697
| – | – |
|
9
Precision BioSciences
DTIL
$56.9M
| $384K | 0.86% |
1,123,913
| – | – |
|
10
Spero Therapeutics
SPRO
$114M
| $301K | 0.68% |
249,070
| – | – |
|
|
IMA
11
ImageneBio, Inc. Common Stock
IMA
$150M
| $116K | 0.26% |
+26,833
| New | +$116K |
|
12
Q32 Bio
QTTB
$20.5M
| $74.9K | 0.17% |
64,000
| – | – |
|
|
DICE
13
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| – | – |
-268,346
| Closed | -$12.5M |
|